IP Library Granted Patent US 9,101,708
Granted Patent B2
US 9,101,708 · App. 11/073,910 · Granted Aug 11, 2015

Powerhead control in a power injection system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,101,708
App. No.
11/073,910
Granted
Aug 11, 2015
Kind
B2
Abstract

A dual head contrast media injection system performs a patency check or test injection, determining flow rate and/or flow volume from the programmed protocol. The tubing that connects syringes to a patient shares only a short common section near to the patient. Appropriate injection steps are taken to compensate for tubing elasticity. A wireless remote control and a touch screen control are provided, improving functionality and information delivery. The display brightness is controlled based on the ambient light, and the display panel includes a double swivel permitting re-orientation. The orientation of the display may also be controlled based on, e.g., the current step, the tilt angle of the powerhead, or a manual control. Furthermore, the display is customizable to identify the type of fluid (contrast, saline, etc.) on either side of the injector, to provide matched color coding, and to provide a folder/tab analogy for retrieving injection protocol parameters.

Claims (11)

1. A contrast media injector system comprising:

a powerhead including a display screen;

the powerhead configured to control injection of a fluid from within a fluid container coupled thereto to a patient through tubing connected to the fluid container;

a first iconic graphical element within the display screen representing the fluid container and the fluid therein, wherein a color of the graphical element is selected based on an identity of the fluid; and

a second iconic graphical element within the display screen representing the tubing and the fluid therein, wherein a color of the second iconic graphical element is substantially identical to the color of the first iconic graphical element, and wherein the second iconic graphical element extends from the first iconic graphical element on the display screen.

2. The system of claim 1 , wherein a color of the first iconic graphical element representing the fluid container and the fluid is yellow if the fluid is saline.

3. The system of claim 1 , wherein a color of the first iconic graphical element representing the fluid container and the fluid is purple if the fluid is contrast media.

4. The system of claim 1 , wherein a color of the first iconic graphical element representing the fluid container and the fluid is black if the fluid is air.

5. The system of claim 1 , wherein the first iconic graphical element representing the fluid container and the fluid and the second iconic graphical element representing the tubing indicate a level of the fluid within the fluid container and connected tubing, respectively.

6. The system of claim 1 , wherein the powerhead is a dual head powerhead and the display screen includes the first iconic graphical element for a first syringe connected thereto and a third iconic graphical element for a second syringe connected thereto, wherein a respective color for each of the first and third iconic graphical elements is dependent on a respective fluid associated with each of the first and second syringes.

7. The system of claim 6 , further comprising respective first and second tubing connected to the first and second syringes, the display screen including the second iconic graphical element for the first tubing and a fourth iconic graphical element for the second tubing, wherein the second and fourth graphical elements are colored substantially similar to the color of the first and third iconic graphical elements, respectively, and wherein the fourth iconic graphical element extends from the second iconic graphical element on the display screen.

Assignments (1)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →